Schwartz Aharon
SEC CIK 1625184 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics, Inc. | Dir | 7,500 | $362.6K | — | 3 | 2023-01-03 | 2025-09-03 |
Most active insiders at PLX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bashan Dror | Pres AND CEO, Dir | $101.4K | — |
| 2 | Bar-Shalev Amos | Dir | — | $314.16 |
Schwartz Aharon made no open-market trades at PLX in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-09-04 | 2025-09-03 | PLX | Protalix BioTherapeutics, Inc. | Schwartz Aharon | Dir | A - Grant | — | +7,500 | 7,500 | New | — |
| 2025-08-12 | 2025-06-10 | PLX | Protalix BioTherapeutics, Inc. | Schwartz Aharon | Dir | P - Purchase | $1.60 | +129.0K | 303.0K | +74% | +$206.4K | |
| 2023-01-05 | 2023-01-03 | PLX | Protalix BioTherapeutics, Inc. | Schwartz Aharon | Dir | P - Purchase | $1.42 | +110.0K | 174.0K | +172% | +$156.2K |
Purchase Sale Sale after option exercise All abbreviations